Replies to post #55135 on Ayala Pharmaceuticals Inc (fka ADXS)

[jckrdu]

I didn't report that, but the link I posted on clinicaltrials.gov should have the locations. 111 total sites.

My read of the Advaxis/Stendhal deal is that Aim2serv is one trial (maybe with some locations in Latin American countries), but that other separate trials were contemplated as well.

Maybe the plan is to get Aim2serv Phase 3 results and then Stendhal will use those results to seek approval in Latin American countries.